In this episode, Vanessa Blumer, MD, FACC, and Ersilia M. DeFilippis, MD, FACC, discuss the 2024 ACC Expert Consensus Decision Pathway for Treatment of Heart Failure with Reduced Ejection Fraction ...

Studies have shown that social isolation and loneliness are important risk factors for cardiovascular disease, but less has been known about their specific connection with heart failure. A new study ...

Sleep is a critical physiological process that allows the body to rest, repair and rejuvenate and it has profound implications for systemic health, particularly the cardiovascular system. Along with ...

The 2023 European Society of Hypertension (ESH) and 2017 American College of Cardiology/American Heart Association (ACC/AHA) hypertension guidelines both emphasize proper blood pressure (BP) ...

Alpha-Gal Syndrome (AGS) is an underrecognized, tick-borne allergic condition with emerging relevance in cardiovascular medicine. Sensitization to galactose-α-1,3-galactose (alpha-gal), a ...

Beta-blocker therapy following myocardial infarction (MI) was the primary focus of a hot line session at ESC Congress 2025. Study investigators presented findings from the REBOOT-CNIC and ...

Psychological stress and mental health concerns are both risk factors for and possible complications of cardiovascular disease (CVD). These connections have been recognized in publications dating back ...

The U.S. Food and Drug Administration (FDA) announced on April 15 that Abbott/Thoratec Corp. is recalling the Heartmate II and Heartmate 3 Left Ventricular Assist System (LVAS) due to long-term ...

Global death counts due to cardiovascular disease (CVD) increased from 12.4 million in 1990 to 19.8 million in 2022, reflecting global population growth and aging and the contributions from ...

Semaglutide, the popular anti-obesity medication originally developed to treat diabetes, continues to show cardiovascular benefits beyond weight loss, including reducing risk of death, reducing ...

A new nasal spray form of bumetanide may reduce the tissue swelling caused by heart failure (HF) as effectively as the standard oral and intravenous formulations of the loop diuretic, based on ...

In an effort to expand the collection of real-world data on patients undergoing renal denervation (RDN) across hospitals in the U.S., the ACC and the Richard A. and Susan F. Smith Center for Outcomes ...